MedPath

Amnioreduction in Polyhydramnios

Not yet recruiting
Conditions
Polyhydramnios
Registration Number
NCT07067593
Lead Sponsor
Assiut University
Brief Summary

The aim of this work is to review the indications, procedural complications and outcomes of amnioreduction in pregnancies complicated by polyhydramnios.

Detailed Description

Polyhydramnios is the presence of excessive amniotic fluid in the amniotic sac and it's prevalence reaches 2% of all pregnancies . Polyhydramnios is diagnosed based on ultrasound criteria, as an amniotic fluid index (AFI) \>25 cm or maximal vertical pocket \> 8 cm . There is a recognized association of polyhydramnios and adverse pregnancy outcomes, including perinatal death, fetal abnormality and preterm birth . Management of the pregnancy can be problematic, particularly in severe cases, due to issues surrounding maternal discomfort and the risk of preterm birth. Amnioreduction, widely used in the management of polyhydramnios, is an option available to palliate maternal symptomatology and potentially prolong the pregnancy . Previous publications have shown a reduction in the risk for premature rupture of membranes and preterm labor decrease, placental perfusion improvement, and relief of maternal discomfort following amnioreduction

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
28
Inclusion Criteria
  • Pregnant women 20- 38 weeks
  • Patients with polyhydramnios

Exclusion criteria:

  • Lethal fetal anomalies
  • Pre labor rupture of membranes
  • Placental separation
  • Chorioamnionitis
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gestational age at delivery4 months

Determine Gestational age at delivery in polyhydramnios patients . Increased age is good.

Rate of PROM4 months

Number of cases developed PROM

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Women's Health Hospital

🇪🇬

Assiut, Egypt

Women's Health Hospital
🇪🇬Assiut, Egypt
Mohamed Fekry
Contact
0882312388
mohamedbeethoven2040@gmail.com
Mohamed Fekry, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.